Alan Kutner
Internal Medicine · Miami Beach, FLNPI 1265438386
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 164 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by Novo Nordisk at 24.3% of the total. Reporting peaked in 2022 at $1,116 and has fallen 87.4% since, to $141 in 2023.
Across 164 payments — averaging $21.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$858
- Bayer$442
- Takeda Pharmaceuticals U.S.A., Inc.$315
- AstraZeneca$297
- AbbVie$296
- Astellas Pharma US Inc$241
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,45598%
- Education$752%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 30 | $858 |
| Bayer | 14 | $442 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $315 |
| AstraZeneca | 19 | $297 |
| AbbVie(2 entities) | 11 | $296 |
| Astellas Pharma US Inc | 12 | $241 |
| Pfizer | 7 | $126 |
| Amgen(2 entities) | 7 | $119 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $117 |
| Amarin Pharma, Inc. | 6 | $103 |
| Gilead | 3 | $69 |
| Lilly USA, LLC | 5 | $69 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $52 |
| Johnson & Johnson | 3 | $47 |
| Biohaven Pharmaceuticals, Inc. | 3 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Upsher-smith Laboratories LLC | 2 | $35 |
| Shire North American Group Inc | 2 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| Amneal Pharmaceuticals LLC | 2 | $30 |
| Novartis | 2 | $29 |
| Boehringer Ingelheim | 1 | $23 |
| Redhill Biopharma Inc. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Bristol Myers Squibb | 1 | $16 |
| Eisai Inc. | 1 | $16 |
| QOL Medical, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$235
- RYBELSUS$125
- Creon$125
- Kerendia$117
- TRINTELLIX$114
How this compares
$3,530 in reported general payments places this provider in the 85th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Miami Beach
- Jason ShapiroMiami Beach$69K
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.